Your browser doesn't support javascript.
loading
EGFR inhibitors: clinical aspects, risk factors and biomarkers for acneiform eruptions and other mucosal and cutaneous adverse effects.
Recuero, Júlia Kanaan; Fitz, Joana Roberta; Pereira, Andrea Abe; Bonamigo, Renan Rangel.
Affiliation
  • Recuero JK; Postgraduate program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil; Dermatology Service, Irmandade Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, RS, Brazil. Electronic address: jkrecuero@gmail.com.
  • Fitz JR; Dermatology Service, Irmandade Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, RS, Brazil.
  • Pereira AA; Postgraduate program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil.
  • Bonamigo RR; Postgraduate program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil; Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
An Bras Dermatol ; 98(4): 429-439, 2023.
Article in En | MEDLINE | ID: mdl-36990917
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acneiform Eruptions / Drug-Related Side Effects and Adverse Reactions / ErbB Receptors / Antineoplastic Agents Type of study: Etiology_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans Language: En Journal: An Bras Dermatol Year: 2023 Document type: Article Country of publication: Spain
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acneiform Eruptions / Drug-Related Side Effects and Adverse Reactions / ErbB Receptors / Antineoplastic Agents Type of study: Etiology_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans Language: En Journal: An Bras Dermatol Year: 2023 Document type: Article Country of publication: Spain